지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Objectives : The purpose of this study is to compare laboratory blood test markers in patients with mild cognitive impairment(MCI) and Alzheimer’s disease(AD) among elderly over the age of 65.
Methods : 176 subjects who scored lower 1.5SD of the Korean version of Mini-Mental State Examination(MMSEKC) were evaluated using the Korean version of the Consortium to Establish a Registry for AD(CERAD-KC) and Clnical dementia Rating(CDR) and Global Deterioration Scale(GDS). 70 subjects scored over 0.5 in CDR and they were divided into two subgroups. 24 subjects was diagnosed with AD. And 40 subjects was diagnosed with MCI. We evaluated them with laboratory test and demographic factors.
Results : According to the demographic data, there was a correlation between old age/low level of education and AD. Regarding the laboratory findings of total cholesterol level and total bilirubin level. There were significant differences between Alzheimer’s disease and mild cognitive impairment(p＜0.05).
Conclusion : There were correlations between Alzheimer’s disease(AD) and high serum total cholesterol level/low serum total bilirubin level.
Methods : 176 subjects who scored lower 1.5SD of the Korean version of Mini-Mental State Examination(MMSEKC) were evaluated using the Korean version of the Consortium to Establish a Registry for AD(CERAD-KC) and Clnical dementia Rating(CDR) and Global Deterioration Scale(GDS). 70 subjects scored over 0.5 in CDR and they were divided into two subgroups. 24 subjects was diagnosed with AD. And 40 subjects was diagnosed with MCI. We evaluated them with laboratory test and demographic factors.
Results : According to the demographic data, there was a correlation between old age/low level of education and AD. Regarding the laboratory findings of total cholesterol level and total bilirubin level. There were significant differences between Alzheimer’s disease and mild cognitive impairment(p＜0.05).
Conclusion : There were correlations between Alzheimer’s disease(AD) and high serum total cholesterol level/low serum total bilirubin level.
목차
서론
대상 및 방법
결과
고찰
결론
참고문헌
참고문헌 (39)
참고문헌 신청
1. [학술지(정기간행물)] - Petersen RC / 2001 / Current concepts in mild cognitive impairment / Arch Neuro 58 : 1985 ~ 1992
2. [학술지(정기간행물)] - Peterson RC / 2007 / Mild cognitive impairment:current research and clinical implications / Semin Neurol 27 : 22 ~ 31
3. [학술지(정기간행물)] - Petersen RC / 1999 / Mild cognitive impairment:Clinical characterization and outcome / Arch Neurol 56 : 303 ~ 308
4. [학술지(정기간행물)] - Winblad B / 2004 / Mild cognitive impairment beyond-controversies,towards a consensus:Report of the International Working Group on Mild cognitive impairment / J Intern Med 256 : 240 ~ 246
5. [학술지(정기간행물)] - Andreasen N / 2001 / Evaluation of CSF-tau and CSF-Aβ-42 as diagnostic markers for Alzheimer’s disease in clinical practice / Arch neurol 58 : 373 ~ 379
2. [학술지(정기간행물)] - Peterson RC / 2007 / Mild cognitive impairment:current research and clinical implications / Semin Neurol 27 : 22 ~ 31
3. [학술지(정기간행물)] - Petersen RC / 1999 / Mild cognitive impairment:Clinical characterization and outcome / Arch Neurol 56 : 303 ~ 308
4. [학술지(정기간행물)] - Winblad B / 2004 / Mild cognitive impairment beyond-controversies,towards a consensus:Report of the International Working Group on Mild cognitive impairment / J Intern Med 256 : 240 ~ 246
5. [학술지(정기간행물)] - Andreasen N / 2001 / Evaluation of CSF-tau and CSF-Aβ-42 as diagnostic markers for Alzheimer’s disease in clinical practice / Arch neurol 58 : 373 ~ 379
이 논문의 저자 정보
이 논문과 함께 이용한 논문
경도인지장애와 알츠하이머병 환자에서 뇌량 크기의 비교
송영헌
,
김재민
,
김성완
외 4명
생물치료정신의학
2010
.12
경도인지장애와 알츠하이머병에서 삶의 질
김석헌
,
김선영
,
배경렬
외 4명
생물치료정신의학
2012
.12
알쯔하이머병 노인들의 인지기능과 관련된 식이 요인
정경아
,
이요아
,
김성윤
외 1명
한국영양학회지
2008
.12
경도인지장애와 알츠하이머형 치매 환자에서 혈중 Superoxide Dismutase 활성도와 Nitric oxide 및 Homocysteine 농도
김지은
,
정성수
,
이정구
외 8명
생물치료정신의학
2007
.12
초기 알츠하이머병 환자와 주요 우울증 환자의 기억기능 비교
이지성
,
배금예
,
이정재
외 1명
생물치료정신의학
2010
.12
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2013-513-000478025